{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:31:16Z","timestamp":1782743476549,"version":"3.54.5"},"reference-count":52,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,6,15]],"date-time":"2007-06-15T00:00:00Z","timestamp":1181865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> A number of recent case reports and case series suggest that proton pump inhibitors may cause acute interstitial nephritis.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To establish the nature of the relationship (cause or association) between proton pump inhibitor use and development of interstitial nephritis.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Data collection: Two researchers independently searched electronic databases (MEDLINE, EMBASE, GOOGLE, LILACS, COCHRANE) for articles from 1970 to 2006, including all study designs, populations and languages. Two independent reviewers assessed study quality and collected the data. Selection criteria: absence of baseline renal failure, development of interstitial nephritis after proton pump inhibitor exposure, nephritis confirmed by creatinine plus either renal biopsy or recurrence upon reinitiating proton pump inhibitor.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Sixty four cases (60% females, mean age 78\u2003years) of proton pump inhibitor\u2010associated interstitial nephritis were found, 60 included in this review (59 confirmed by renal biopsy, one by recurrence upon reinitiating proton pump inhibitor). The most common symptoms were non\u2010specific. The mean proton pump inhibitor treatment duration before diagnosing nephritis was 13\u2003weeks, average recovery time was 35.5\u2003weeks, one patient required permanent dialysis, there were no deaths.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Proton pump inhibitor\u2010related interstitial nephritis is rare, idiosyncratic and difficult to predict. It requires a high level of clinical suspicion. While there is not sufficient evidence to establish a causal relationship with certainty, there does appear to be a low\u2010prevalence association.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2007.03407.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T12:03:13Z","timestamp":1279886593000},"page":"545-553","source":"Crossref","is-referenced-by-count":128,"title":["Systematic review: proton pump inhibitor\u2010associated acute interstitial nephritis"],"prefix":"10.1111","volume":"26","author":[{"given":"F.","family":"SIERRA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"SUAREZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"REY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"VELA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,15]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"IMS Health IMS National Sales PerspectivesTM 1\/2006. Available at:http:\/\/www.imshealth.com(accessed 15 March 2007)."},{"issue":"1","key":"e_1_2_6_3_2","first-page":"113","article-title":"Potent acid inhibition: summary of the evidence and clinical application","volume":"65","author":"Mearin F","year":"2005","journal-title":"Drugs"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00651.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh137"},{"issue":"7","key":"e_1_2_6_6_2","first-page":"12","article-title":"Acute interstitial nephritis in the elderly: a report from the UK MRC Glomerulonephritis Register and a review of the literature","volume":"13","author":"Davison AM","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_7_2","first-page":"221","article-title":"Renal biopsy in patientes with unexplained renal impairment and normal size kidney","volume":"70","author":"Farrington K","year":"1989","journal-title":"Q J Med"},{"key":"e_1_2_6_8_2","first-page":"2527","article-title":"Diagnosis and management of acute interstitial nephritis","volume":"67","author":"Kodner CM","year":"2003","journal-title":"Am Fam Physician"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V93506","article-title":"Acute interstitial nephritis","volume":"9","author":"Michel DM","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg464"},{"issue":"1","key":"e_1_2_6_11_2","first-page":"97","article-title":"Safety of potent gastric acid inhibition","volume":"65","author":"Martin C","year":"2005","journal-title":"Drugs"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0540"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00675.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.11.004"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0076"},{"key":"e_1_2_6_16_2","first-page":"A384","article-title":"Proton pump inhibitors: the most common iatrogenic cause of acute interstitial nephritis","volume":"10","author":"Geevasinga N","year":"2005","journal-title":"Nephrology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09425.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06675.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1130-6343(05)73653-9"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2005.00365.x"},{"key":"e_1_2_6_21_2","first-page":"A287","article-title":"Proton pump inhibitor\u2010induced acute interstitial nephritis","volume":"4","author":"Geevasinga N","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_2_6_22_2","first-page":"580","article-title":"Pantoprazole\u2010induced acute interstitial nephritis","volume":"17","author":"Moore I","year":"2004","journal-title":"J Nephrol"},{"issue":"3","key":"e_1_2_6_23_2","first-page":"61","article-title":"Acute interstitial nephritis associated with omeprazole therapy","volume":"24","author":"Torregrosa E","year":"2004","journal-title":"Nefrologia"},{"key":"e_1_2_6_24_2","first-page":"21","article-title":"Nephritis and proton pump inhibitors","volume":"13","author":"Anonymous","year":"2004","journal-title":"Prescrire Int"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D085"},{"key":"e_1_2_6_26_2","first-page":"U332","article-title":"Omeprazole\u2010induced acute interstitial nephritis","volume":"116","author":"Delve P","year":"2003","journal-title":"N Z Med J"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7753(02)72274-4"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.05345.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00152193-200030100-00039"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.9.1450"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(00)00044-9"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.03375.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.74.873.416"},{"key":"e_1_2_6_34_2","first-page":"618","article-title":"Interstitial nephritis caused by omeprazole","volume":"15","author":"Segarra Soria MA","year":"1998","journal-title":"An Med Interna"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013345"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.11.2414"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199709000-00011"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(199707)6:4<247::AID-PDS296>3.0.CO;2-O"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.3109\/08860229709026272"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70212-9"},{"key":"e_1_2_6_41_2","first-page":"129","article-title":"Acute interstitial nephritis due to omeprazole","volume":"44","author":"Fleury D","year":"1995","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_42_2","first-page":"14","article-title":"Omeprazole and musculoskeletal problems and interstitial nephritis","volume":"14","author":"Australian Adverse Drug Reactions Advisory Committee","year":"1995","journal-title":"Aust Adverse Drug React Bull"},{"key":"e_1_2_6_43_2","first-page":"459","article-title":"Acute interstitial nephritis due to omeprazole","volume":"11","author":"Santostefano M","year":"1994","journal-title":"G Ital Nefrol"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1994.tb01765.x"},{"key":"e_1_2_6_45_2","first-page":"280","article-title":"Acute interstitial nephritis, omeprazole and antineutrophil cytoplasmic antibodies","volume":"42","author":"Singer S","year":"1994","journal-title":"Clin Nephrol"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91674-8"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91945-3"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90273-R"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92531-W"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90181-A"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-7-199710010-00005"},{"key":"e_1_2_6_52_2","first-page":"187","volume-title":"Clinical Epidemiology The Essentials","author":"Fletcher R","year":"2005"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03407.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03407.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:03:07Z","timestamp":1697234587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03407.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,15]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03407.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03407.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,15]]}}}